Amiodarone Side Effects, FDA
ALERT
November 12, 2005
Amiodarone hydrochloride (marketed as Cordarone) Information



FDA ALERT [05/2005] – Pulmonary toxicity, Hepatic Injury, and Worsened
Arrhythmia

Amiodarone may cause potentially fatal toxicities, including pulmonary toxicity,
hepatic injury, and worsened arrhythmia.

Amiodarone should only be used to treat adults with life-threatening ventricular
arrhythmias when other treatments are ineffective or have not been tolerated.

This information reflects FDA's preliminary analysis of data concerning this
drug. FDA is considering, but has not reached a final conclusion about, this
information.
PHARMCEUTICAL
INDUSTRY

Foundamental
Science
Colloidal
Stabilization

Drug Product
Development
Patent Application
Product
Development
Product
Ingredients
Colorant
Scale up a batch 1
Drug Delivery
Industry
Drug Delivery -
Smart Bomb
Lotion, Cream,
Preps
Enteric
Coating-Eudragit
Enteric
Coating-Nutrateric
SR
Coating-Aquacoat

Drug Industry
Drug
Competitions
Drug in
Development
Cholesterol-loweri
ng
Drug-Terminologi
es
Packaging
Materials

Market
Drug Dev- 2004
Drug Dev -
2005Q1
Drug Dev- 2005Q2

Drug
Dev-2005Summer
Drug Dev-2005Q3
Orphan Drug
Protein Drug
Niche Market

Novo Norkdisk
R&D

Equipment
Blenders

CONTRACT
MANUFACT.
Nutrition
Supplements

NEW DRUGS
Arranon
Actoplus Met
Alfuzosin
Ambien CR
Avastin
Asmanex(R)
Erbitux
(cetuximab)
Gardasil
GRN163
Herceptin
Increlex (rhIGF-1)
Lidoerm
(Lidocaine)
Liraglutide
Lyrica (pregabalin)

Rozerem
Sorafenib
Sutent
Tamsulosin
Torcetrapib
Zometa
OLD DRUGS
Lithium Carbonate

DRUG NOTES
[CONSTRUCT]
Clinical Research
Terminologies
FDA ALERTS
Protein Drug
Market
Niche Market
Orphan Drug
levothyroxine
Protein Drug 1
Protein Drug2

Double-blind
Study